Navigation Links
Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
Date:11/18/2009

Promega Corporation and SwitchGear Genomics announce a novel method for characterizing DNA-protein interactions.

Madison, WI, USA (PRWEB) November 18, 2009 -- Promega Corporation and SwitchGear Genomics announce a novel method for characterizing DNA-protein interactions. Results of a study using the HaloCHIP™ System and high-throughput promoter assays demonstrate the ability to correlate DNA binding events to transcriptional activation or repression for the CREB transcription factor. The findings appear in the article “A functional analysis of the CREB signaling pathway using HaloCHIP-chip and high throughput reporter assays”, recently published in BMC Genomics online.

This combination of technologies enables discovery of genome-wide DNA binding sites for transcription factors and the functional activities of the promoter sequences bound by those transcription factors. “This comprehensive approach enables the comparison between binding events and transcriptional activity,” said Nathan Trinklein, Ph.D., co-founder and CEO of SwitchGear Genomics. “Characterizing the functional consequences of binding events is essential to more fully understanding the control of gene expression.”

HaloCHIP, which uses Promega HaloTag® Technology, eliminates the need for antibodies to capture protein:DNA complexes, thereby avoiding one of the major challenges of chromatin immunoprecipitation (ChIP) techniques.

“HaloCHIP allows researchers to more easily and efficiently capture genome-wide protein-DNA complexes starting with a much smaller number of cells,” stated Danette Hartzell, Senior Research Scientist at Promega Corporation. “This antibody-free method for revealing DNA binding events in combination with functional reporter assays can significantly advance gene regulation studies.”

About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit www.promega.com

About SwitchGear Genomics, Inc.
SwitchGear Genomics Inc. is a leading provider of products for studying the regulatory elements in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory networks and allow researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Myers, Dr. Nathan Trinklein and Dr. Shelley Force Aldred from Stanford University. For more information about SwitchGear, please visit the company's website at www.switchgeargenomics.com

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3216534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Promega HaloTag Protein Purification System Makes it Easier to Purify Difficult-to-Express Proteins
2. New STR Systems from Promega Comply with Latest DNA Database Standards
3. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
4. Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes
5. Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
6. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
7. Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity
8. Boston University Periodontal Study on Imagenetix Compound Published in The Journal of Periodontology
9. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
10. Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
11. Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
(Date:2/21/2017)... ... 21, 2017 , ... Cancer diagnostics workflow solution provider Inspirata, ... team to lead the development and commercialization of its Cancer Information Data Trust ... and treatment of cancer. The CIDT addresses the need for curated and structured ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... and manufacturing solutions for original equipment manufacturers (OEMs) , today announced it has ... Technologies’ third consecutive year winning in its category of electronics manufacturing services (EMS) ...
(Date:2/21/2017)... , February 21, 2017 ... Technology for Adoption by Plastic Industry  ... STEER, creator ... functionalise materials in the fields of plastics, pharmaceuticals, food and ... with Merck, a leading science & technology company, on ...
(Date:2/20/2017)... , Feb. 20, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... President and CEO and Fabrice Orecchioni, the company,s COO, has been ... COO over the past four years, Fabrice has overseen the construction, ... and the management of the Mitsui JV.  Fabrice has ... the proposed China JV. ...
Breaking Biology Technology:
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
Breaking Biology News(10 mins):